For the New York Mets‘ offense, it’s important to have someone who can get on base regularly so that the sluggers, namely Pete Alonso, Francisco Lindor, Eduardo Escobar, JD Davis or Dom Smith, have people to drive in.
For the last few years, Brandon Nimmo has fulfilled that role: he is the catalyst of the Mets’ offense, highlighted by his excellent .393 career OBP.
The Mets, however, are currently going through a bit of a rough patch with injuries: Jacob deGrom is out for a couple of months, Max Scherzer is questionable for Opening Day, and now Nimmo has been added to that list.
“Brandon Nimmo received a cortisone-type injection in his neck. He’s still uncertain for Opening Day, but ‘we should get good results,’ Buck Showalter said. He’s optimistic about Thursday,” Mets’ beat writer for MLB.com Anthony DiComo tweeted on Tuesday.
Brandon Nimmo received a cortisone-type injection in his neck. He's still uncertain for Opening Day, but "we should get good results," Buck Showalter said. He's optimistic about Thursday.
— Anthony DiComo (@AnthonyDiComo) April 5, 2022
In any case, if he misses time, Nimmo shouldn’t be out for long, as it doesn’t sound like an issue that will send him to the injured list.
The Cortisone Shot Should Help Him Heal
The Mets, however, have learned over the last couple of years to give their players enough time to heal.
The hope, in this particular case, is that the cortisone shot helps his neck feel good enough to take the field again.
Together with Starling Marte, Nimmo will be tasked with getting on base at a high clip for the Mets.
In 386 plate appearances last year, Nimmo hit a fabulous .292/.401/.437, with eight home runs, five stolen bases, and 51 runs scored.
Defensively, he improved in center field last year, but after Marte’s arrival, he is expected to move to one of the corners.
The Mets are hoping to have one of their most important lineup pieces back soon.